4 funding opportunities found in this category. 

American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease
American College of Cardiology Foundation/Merck
All Regions
09/23/2013
$70,000

American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease

Four one-year fellowships will be awarded to support research in adult cardiology. Preference is given to individuals who have had no more than two years of prior full-time experience either in clinical or basic research. Recipients will be expected to pursue a full-time project in clinical research during their year of supported training.

Research Focus: In selecting applications, proposals addressing CVD and Cardiometabolic disorders are encouraged. Included are proposals that address pathophysiology, molecular genetics, metabolic abnormalities leading to cardiovascular disease, hypertension, heart failure, hyperlipidemia, inflammatory mechanisms and new pathways for drug discovery. Proposals focusing on clinically relevant outcomes as a result of the metabolic syndrome, diabetes or obesity are also encouraged. Outcomes studies should focus on clinical/and or systems of care (e.g., quality improvement) interventions, and use outcomes measures of importance to both patients and society, including mortality, significant morbidity or quality of life changes, or economic effects.

Preference for one award will be given to applicants focusing on disparities of care.  Despite increased attention to health disparities at the national, state and community levels, relatively little progress has been made in achieving the vision of eliminating racial and ethnic health disparities.  Since the rates of cardiovascular mortality in the United States are significantly higher for these patients and this is, in fact, the leading cause of death in this demographic, innovative approaches to eliminating these disparities are critical.  In an effort to encourage and support research in this area, proposals will be encouraged that focus on gender, race, geographic, and economic inequalities in cardiovascular care.

Eligibility: Anyone currently in an adult cardiology fellowship training program recognized by the Accreditation Council for Graduate Medical Education or the American Osteopathic Association and who has the recommendation and agreement of his/her training program director and institution.

Selection: Judging will be by the ACCF/Research Fellowship Awards Committee. Criteria for selection will include:

• Scientific quality of the project;

• Relevance to the research focus as described above;

• Qualifications and commitment of the applicant; and

• The quality of the training environment.

Successful applicants may pursue this protected year of research either within or following their three years of required training. Preference will be given to individuals who:

• Will pursue clinical research training and experience directly involving patients or human subjects.

• Have had no more than two years of prior full-time research experience either in clinical or basic research.

• Will not hold another major external fellowship or salary award, (e.g., from the National Institutes of Health or the American Heart Association) during the ACCF/Merck funded year.

The Award: Four fellowships in the amount of $70,000 each, to be used for salary support, for one year of research to begin July 1, 2014 and run through June 30, 2015.

Funding Source: The ACCF is grateful to the Merck Company Foundation for their continued financial support for these awards.

Deadline: September 23, 2013

For more information: Email Julia Berman or call 800-253-4636, ext. 6648.

Postdoctoral Fellow
Request for Proposals: 2013 ASPIRE Awards in Adult Vaccine Research
Pfizer
All Regions
07/02/2013
$100,000

Request for Proposals: 2013 ASPIRE Awards in Adult Vaccine Research

Mission

The mission of the 2013 ASPIRE Awards in Adult Vaccine Research is to advance medical knowledge to better understand the burden of pneumococcal disease in adults.

The burden of pneumococcal disease in the general adult population has been extensively studied; however, it is not well-defined in special populations, including subgroups with underlying disease comorbidities and/or those living in long-term community settings.

Pfizer invites investigators to apply for the 2013 ASPIRE Awards in Adult Vaccine Research through submission of innovative research proposals for evaluation of the epidemiology and burden of pneumococcal disease in adults with underlying disease comorbidities and/or those living in long-term community settings.

2013 Research Topic

Evaluating the Burden of Pneumococcal Disease in Adults in the United States

An applicant should have a strong research interest within the areas of focus and should consider the following components when developing their research proposals:

A. The burden of pneumococcal disease and serotype distribution in adults including but not limited to:

• Individuals with increased risk of pneumococcal disease including those with underlying comorbidities.

Comorbidities may include but are not limited to:

◦ Diabetes mellitus

◦ Chronic obstructive pulmonary disease (COPD) or other chronic pulmonary disorder

◦ Oncologic disorders

◦ Chronic renal disease

◦ Hepatic disease

◦ Autoimmune disorders

• Those living in community settings (e.g., extended-care facilities, correctional institutions).

• Regional evaluation of pneumococcal resistance and serotype distribution.

• Carriage of Streptococcus pneumoniae in the adult population.

B. Association of pneumococcal pneumonia with influenza or other respiratory viral illnesses

C. The following topics fall outside of the scope of the ASPIRE Adult Vaccine Research Program:

• General education and / or training.

• Support for ongoing clinical programs that are part of an organization’s routine operations.

• Proposals that evaluate populations outside of the United States or Puerto Rico.

Proposals whose primary objective is to financially quantify outcomes as it relates to a Pfizer product(s) are outside the scope of the program.

Research Expectations

Within the specified patient populations of interest, investigators are expected to:

• Generate data regarding the burden of pneumococcal disease in adults and/or evaluation of adult vaccination efforts.

• Be able to complete the research in 12 months.

• Present and/or publish the results of the study.

Available Awards

Pfizer is funding research awards up to a maximum of $100,000 USD* each (including direct costs, institutional overhead costs, and indirect costs) for one year to conduct research generating data that will lead to a better understanding of burden of pneumococcal disease in adults.

*Please note that study budgets will be evaluated separately to ensure the requested funding is commensurate with the work proposed.

Deadline for Application

Applications must be received by 11:59pm EST on July 2, 2013. 

Physician Researcher, Virologist, Epidemiologist
Call for Applications: American Diabetes Association Pathway to Stop Diabetes Diabetes Research Accelerator Award
American Diabetes Association
All Regions
08/16/2013
$1,625,000

Call for Applications: American Diabetes Association Pathway to Stop Diabetes Diabetes Research Accelerator Award

Application Deadline: August 16, 2013 for January 2014 funding

Awards are designed to support exceptional early-career researchers who have distinguished themselves as promising investigators and are in the beginning stages of establishing successful, independent diabetes research programs; and talented established investigators in fields other than diabetes who are interested in applying their skills and expertise to diabetes research.

Eligibility:

Awards are available to individuals with established records of independent productivity in research, in two distinct categories:

• Early Investigator: Early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K or R awards, including an initial R01) but must not have applied for, or received, an R01 renewal or a second R01 award.

• Established Investigator New to Diabetes Research: Established investigators with exceptional productivity in fields other than diabetes research who would like to apply their expertise to innovative diabetes-related research topics. Applicants must hold faculty positions and have demonstrated independent productivity. Applicants cannot have previously received national grant support in diabetes research.

Candidates will be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.

Support: Awards provide five years of research support at a maximum of $325,000 per year (including 30% indirect costs), for a total of $1,625,000.

Junior Scientist, Young Scientist, Physician Researcher, Junior Researcher, Junior Investigator, Young Investigator, New Investigator, Established Investigator, Endocrinologist, New Researcher
Call for Applications: American Diabetes Association Pathway to Stop Diabetes Diabetes Research Career Initiator Award
American Diabetes Association
All Regions
08/16/2013
$1,625,000

Call for Applications: American Diabetes Association Pathway to Stop Diabetes Diabetes Research Career Initiator Award

Application Deadline: August 16, 2013 for January 2014 funding

This two-phased award is designed to support the transition from mentored training to independent research faculty

Eligibility:

Eligible applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of training following terminal doctoral degree.

Candidates will be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.

Support:

Awards provide two distinct phases of research support. Phase 1 provides up to two years of support for mentored training at a maximum of $100,000 per year (including 10% indirect costs). Phase 2 provides up to five years of support for independent research at a maximum of $325,000 per year (including 30% indirect costs).

Combined support for Phase 1 and Phase 2 can total up to $1,625,000.

Junior Scientist, Young Scientist, Junior Researcher, Junior Investigator, Young Investigator, New Investigator, New Researcher